Salicyclic Acid Active Ingredients TRIZ Cases
- MAIT Cell Inhibition for Targeted Liver Fibrosis Treatment
Selective MAIT cell inhibition reduces profibrogenic inflammation in chronic liver injury while avoiding broad immunosuppression.
- PEAR1 Agonist Hemostasis Under Dual Antiplatelet Therapy
PEAR1 agonists sustain platelet aggregation to control surgical bleeding in patients receiving P2Y12-blocking or dual antiplatelet therapy.
- Cannabinoid-Collagen Composition for Musculoskeletal Pain Relief
Combining cannabinoids with Type II collagen supports joint and muscular health while easing pain and inflammation with lower addiction risk.
- Histone Acetyltransferase Inhibitors for HDAC4-Linked Skin Disorders
Histone acetyltransferase inhibitors reduce abnormal HDAC4 expression to help prevent photosensitive skin damage, senescence, and skin cancer.
- Delayed-Release Mesalamine Coating for Targeted Colon Delivery
A multilayer mesalamine formulation uses enteric and hydrophilic coatings to delay intestinal release, improve colon delivery, and reduce dosing burden.
- Bismuth Subsalicylate Suspension With a Lead-Free Three-Gum System
A lead-free three-gum suspension keeps bismuth subsalicylate dispersed without magnesium aluminum silicate, reducing sedimentation and lead risk.
- MAIT Cell Inhibition for Treatment-Resistant Rheumatoid Arthritis
Targeting MAIT cell activation offers a new rheumatoid arthritis treatment path for patients who do not respond to methotrexate or biologics.
- Topical Analgesic Gel With DMSO for Pain Relief Without Numbing
DMSO-driven skin penetration delivers curcumin and other anti-inflammatory agents for rapid joint and muscle pain relief without impairing touch.
- Topical Arrector Pili Stimulation for Traction Alopecia Prevention
Stimulating arrector pili muscles with topical receptor agonists raises hair epilatory force and helps prevent traction alopecia.
- Cervical Tissue Relaxation for Minimally Invasive Insemination
Topical natural substances relax cervical tissue to enable safer transcervical insemination with less damage, infection risk, and anesthesia use.
- Roflumilast Aerosol Foam Composition for Stable Skin Delivery
An alkyl phosphate surfactant blend and propane/isobutane/butane propellant keep roflumilast foam stable for consistent, low-irritation skin delivery.
- Milvexian FXIa Inhibition for Stroke Prevention With Lower Bleeding Risk
Selective FXIa inhibition with milvexian plus antiplatelet therapy lowers recurrent ischemic stroke risk while preserving hemostasis.